Technology
Here’s Why Pfizer and BioNTech Are Selling Their Vaccine at Cost – Motley Fool
The humanitarian move might help the companies gain additional for-profit contracts in the future.
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently agreed to sell their COVID-19 vaccine to the U.S. government at cost. In this video from Motley Fool Live, recorded on June 14, Fool.com contributors Brian Orelli and Keith Speights discuss why the companies…
Continue Reading
-
Noosa News15 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News24 hours agoFarmers sell off record numbers of stock as southern NSW drought bites
-
Business16 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News18 hours ago‘They’re not taking the concerns of women seriously’